Methodological approach to the formation of the list of high-tech medical care types

Background. The implementation of individual methods of high-tech medical care (HTMC) with methods of specialized medical care within the framework of a phased transition to payment methods by diagnostic-related groups (DRGs), on the one hand, significantly expanded the availability of HTMC methods for the population. Still, it created a situation with duplication of individual treatment methods in the list of HTMC types and DRGs. Amendments to the Order of the Ministry of Health of the Russian Federation (MH RF) of August 1, 2017 No. 484n, regulating the revision of HTMC types list in terms of excluding treatment methods and (or) HTMC types in case of their duplication in the context of HTMC groups and/or DRGs, marked the beginning of large-scale work in this area and required methodological ensuring the processes of forming HTMC types list, including in terms of its revision.

Objective: development of a methodological approach to the formation of HTMC types list (using the example of the list for 2023). Material and methods. An analysis of legal documents regulating the HTMC availability in the Russian Federation was carried out, including the list of medical services approved by the Order of the MH RF of October 13, 2017 No. 804n, clinical recommendations for certain nosological entities, the International Classification of Diseases (10th revision), methodological recommendations on ways to pay for medical care at the expense of the compulsory health insurance (CHI) and appendices to them (decoders of DRGs for payment of medical care provided in inpatient and daytime hospital conditions), posted on the official website of the Federal CHI Fund. The frequency of the use of certain HTMC methods and DRGs was analyzed on the basis of impersonalized information from the database of registers of bills for specialized medical care, including HTMC for 2021–2022.

Results. A methodological approach to the revision of HTMC types list was developed. It included its primary analysis, expert discussion of the obtained results, consideration by the Interdepartmental Council of the MH RF of proposals agreed with experts on each HTMC method submitted for discussion, followed by a decision on the appropriateness of the proposed changes, and recalculation of the standard of financial costs for HTMC and/or basic tariff for DRGs.

Conclusion. The proposed methodological approach makes it possible to unify the process of revising the HTMC types list, including the exclusion of duplicate treatment methods and/or HTMC types in the sections of HTMC list types and/or in DRGs, as well as treatment methods missing in clinical recommendations, etc. in order to bring the HTMC types list in accordance with legal documents regulating the provision of medical care in the Russian Federation.

1. Karpov O.E., Silaeva N.A. Organization of a system of high-tech medical care in Russia: the history of the issue (part II). Bulletin of Pirogov National Medical & Surgical Center. 2018; 13 (4): 147–52 (in Russ.).

2. World Health Organization. Health technology assessment and health policy-making in Europe: current status, challenges and potential. 2010. Available at: https://apps.who.int/iris/handle/10665/276988 (accessed 09.03.2023).

3. Solodky V.A., Stupakov I.N., Perkhov V.I., Samorodskaya I.V. Expensive (high-tech) medical care: foreign and domestic experience in the organization of rendering. Health Care Manager. 2016; 1: 5–9 (in Russ.).

4. Glukhova G.A. The state and problems of HTMС development in the Russian economy. Issues of Economics and Management for Healthcare Managers. 2011; 7: 21–8 (in Russ.).

5. Shalygina L.S. Еnsuring availability of hi-tech medical care to population of the Siberian Federal District regions at the federal level health care facilities within the system of compulsory health insurance. Social Aspects of Population Health. 2016; 6 (in Russ.). https://doi.org/10.21045/2071-5021-2016-52-6-3.

6. Kolesnikov S.I., Perkhov V.I. Problems of organization and financing of high-tech medical care in 2017. Acta Biomedica Scientifica. 2016; 1 (5): 77–83 (in Russ.). https://doi.org/10.12737/23395.

7. Karkavina A.N. Problems and prospects of development of high-tech medical care in the Russian Federation. Scientific Notes of the Altai Branch of the Russian Academy of National Economy and Public Administration under the President of the Russian Federation. 2017; 14: 31–4 (in Russ.).

8. Obukhova O.V., Brutova A.S., Bazarova I.N. The problems of transferring high-tech medical care to Russian diagnostic-related groups (ruDRG). Medical Technologies. Assessment and Choice. 2017; 3: 22–30 (in Russ.).

9. Lança L. Health technology assessment: the influence in medical imaging. III Congresso Internacional de Radiologia 2014. https://doi.org/10.13140/2.1.5039.1847.

10. Carniol P.J., Heffelfinger R.N., Grunebaum L.D. Evaluating new technology. Facial Plast Surg Clin North Am. 2018; 26 (2): 253–7. https://doi.org/10.1016/j.fsc.2017.12.009.

11. Hailey D., Werkö S., Rosén M., et al. Influence of health technology assessment and its measurement. Int J Technol Assess Health Care. 2016; 32 (6): 376–84. https://doi.org/10.1017/S0266462316000611.

12. Health Costs. Snapshots: How changes in medical technology affect health care costs. Available at: https://www.kff.org/health-costs/issue-brief/snapshots-how-changes-in-medical-technology-affect/# (accessed 12.03.2023).

13. Kozlovsky V.I., Zanko S.N., Krylov Yu.V., et al. Pharmacoeconomics in cardiology, oncology and obstetrics. Vitebsk: VGMU; 2016: 285 pp. (in Russ.).

14. Jönsson B. Economic evaluation of new medical technology. Scand J Gastroenterol Supply. 1994; 201: 87–90. https://doi.org/10.3109/00365529409105372.

15. Parkin D. The role of economic evaluation and priority setting in health care decision making including the cost effectiveness of public health, and public health interventions and involvement. Available at: https://www.healthknowledge.org.uk/public-health-textbook/medical-sociology-policy-economics/4d-health-economics/health-care-decision-making (accessed 15.03.2023).

16. Rejon-Parrilla J.C., Espin J., Epstein D. How innovation can be defined, evaluated and rewarded in health technology assessment. Health Econ Rev. 2022; 12 (1): 1. https://doi.org/10.1186/s13561-021-00342-y.

17. Gilyarevsky S.P., Orlov V.A., Sycheva E.Y. Economical treatment strategies in cardiology. Russian Journal of Cardiology. 2002; 6 (in Russ.).

18. Worid Health Organization. Health products policy and standards. Health technology assessment. Available at: https://www.who.int/teams/health-product-policy-and-standards/assistive-and-medical-technology/medical-devices/assessment (accessed 12.03.2023).

19. Shishkin S.V., Sheyman I.M., Potapchik E.G., Pankratova O.F. Analysis of the state of insurance medicine in Russia and prospects for its development. Мoscow: Higher School of Economics; 2019: 94 pp. (in Russ.) URL: https://publications.hse.ru/mirror/pubs/share/direct/266095696.pdf (дата обращения 12.03.2023).